Completed NA INTERVENTIONAL 2-arm NCT03154320

A Trial of Same-Day Testing and Treatment to Improve Outcomes Among Symptomatic Patients Newly Diagnosed With HIV

Sponsor: Analysis Group, Inc.

Interventions Same-Day Treatment Standard treatment

Updated 10 times since 2017 Last updated: Sep 6, 2022 Started: Nov 6, 2017 Primary completion: Apr 16, 2021 Completion: Apr 16, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates HIV/AIDS and Tuberculosis and is currently completed. Analysis Group, Inc. leads this study, which shows 10 recorded versions since 2017 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Sep 2022 — Jul 2024 [monthly]

Completed NA

Status: Unknown Status → Completed
Jan 2021 — Sep 2022 [monthly]

Unknown Status NA
Sep 2020 — Jan 2021 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status

▶ Show 5 earlier versions

Sep 2018 — Sep 2020 [monthly]

Recruiting NA
Jun 2018 — Sep 2018 [monthly]

Recruiting NA
Feb 2018 — Jun 2018 [monthly]

Recruiting NA
Dec 2017 — Feb 2018 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Jul 2017 — Dec 2017 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Analysis Group, Inc.
Brigham and Women's Hospital
Florida International University
Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic
University of California, Davis
Weill Medical College of Cornell University

Data source: Brigham and Women's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Port-au-Prince, Haiti